Gilder Gagnon Howe & CO LLC Evolus, Inc. Transaction History
Gilder Gagnon Howe & CO LLC
- $7.02 Billion
- Q1 2025
A detailed history of Gilder Gagnon Howe & CO LLC transactions in Evolus, Inc. stock. As of the latest transaction made, Gilder Gagnon Howe & CO LLC holds 139,145 shares of EOLS stock, worth $1.27 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
139,145
Previous 702,239
80.19%
Holding current value
$1.27 Million
Previous $7.75 Million
78.42%
% of portfolio
0.02%
Previous 0.09%
Shares
3 transactions
Others Institutions Holding EOLS
# of Institutions
187Shares Held
51.9MCall Options Held
142KPut Options Held
58.4K-
Tang Capital Management LLC San Diego, CA5MShares$45.7 Million3.9% of portfolio
-
Perceptive Advisors LLC New York, NY4.13MShares$37.7 Million2.08% of portfolio
-
Black Rock Inc. New York, NY4.01MShares$36.6 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.65MShares$33.4 Million1.98% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.23MShares$29.6 Million0.0% of portfolio
About Evolus, Inc.
- Ticker EOLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 56,094,800
- Market Cap $513M
- Description
- Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...